Matthew Dilallo

These beaten-down dividend stocks look like great buys right now. Higher interest rates have been a double whammy on dividend stocks over the past several quarters.

Meta Platforms' dividend might be small, but it could become mighty. Meta Platforms META shocked many investors by initiating a dividend this year.

Enterprise Products Partners believes it can continue growing value for investors in the future. Enterprise Products Partners EPD

Apple is one of the largest companies in the world. It invests in R&D but also acquires businesses for their talent and tech.

Truth Social's parent company, Trump Media and Technology Group, went public in early 2024. Is it a sensible investment today?

Johnson & Johnson has bought dozens of companies over the years, and will likely acquire more. Here's what you need to know.

Key Points Eli Lilly is a leading global pharmaceutical company. It has developed several blockbuster drugs. It could have another blockbuster on its hands with weight loss drug Zepbound. Motley Fool Issues Rare “All In” Buy Alert The sales potential of Zepbound and the company's other drugs have many investors interested in the stock. Here's everything you need to know about how to invest in Eli Lilly.

Novo Nordisk is a leading global healthcare company. Its breakthrough medications to treat type 2 diabetes and weight loss, including Ozempic and Wegovy, have many people wondering how to invest in the company. Here's what you should know.

Boston Dynamics is a global leader in developing highly mobile robots, with more real-world experience than any other robot developer. Here's what you should know about investing in the company.

A short strangle is an options trading strategy that involves selling a call option and a put option on the same underlying stock with the same expiration date. This article explains what that could mean for you.